FRI-197-Prediction of elastographic reversion of cirrhosis after 5 years of entecavir or tenofovir disoproxil fumarate therapy in caucasian chronic hepatitis B patients

Authors :: Spilios Manolakopoulos
Harry L.A. Janssen
Vana Sypsa
George N. Dalekos
George V. Papatheodoridis
Anastasia Kourikou
Heng Chi
Thomas Berg
Kostas Galanis
Pietro Lampertico
Ioannis Vlachogiannakos
Rafael Esteban
Savvoula Savvidou
Marta López-Gómez
Rhea Veelken
Theodoros Voulgaris
Florian van Bömmel
Bettina E. Hansen
Onur Keskin
Ioannis Goulis
Nikolaos K. Gatselis
José Luis Calleja Panero
Cihan Yurdaydin
Maria Buti
Ramazan Idilman
Alessandro Loglio
Source :: Journal of Hepatology. 70:e477-e478
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: medicine.medical_specialty
Cirrhosis
Hepatology
Tenofovir
business.industry
Reversion
Entecavir
medicine.disease
Gastroenterology
Chronic hepatitis
Internal medicine
medicine
business
medicine.drug

Full Text Access

Tools